Main Article Content

Abstract

Acne vulgaris (AV) is an inflammation of pilosebaceous unit especially in young adult. The pathophysiology is the elevation of sebum production, keratinization of abnormal pilocebaseous follicles, and inflammation caused by immune response to Propionibacterium acnes. Therapy combination of oral antibiotics (doxycycline) and physical therapy (blue light) in moderate-severe acne is one option to reduce antibiotic resistance. Doxycycline is a commonly antibiotic used. The effects of photosensitive can increase the penetration of blue light by sebaceous glands. There was a total decrease in sebum and clinical improvement of combination therapy of blue light and doxycycline in seven patients. The combination therapy has been shown to improve its therapeutic effect, but more clinical trials are needed to prove the effectiveness of blue light with doxycycline than without blue light.

Keywords

Acne vulgaris doxycycline blue light

Article Details

How to Cite
Listiawan, M. Y., Prakoeswa, C. R. S., Handamari, D. A., & Indira, R. (2017). EFFECTS OF BLUE LIGHT EMITTING DIODE (LED) AND DOXYCYCLINE TO SEBACEOUS GLAND IN ACNE VULGARIS. Folia Medica Indonesiana, 53(4), 272–275. https://doi.org/10.20473/fmi.v53i4.7160

References

  1. Ammad S, Gonzales M, Edwards C, Finlay AY, Mills C (2008). An assessment of the efficacy of blue light phototherapy in the treatment of Acne vulgaris. Journal of Cosmetic Dermatol 7, 180–8
  2. Ashkenazi H, Malik Z, Harth Y, Nitzan Y. Eradication of Propionibacterium acnes by its endogenic porphy-rins after illumination with high intensity blue light. FEMS Immunol Med Microbiol 35, 17-24
  3. Bhate K, Williams HC (2012). Epidemiology of acne vulgaris. British Association of Dermatologists 168, 474–85.
  4. Brownell J, Wang S, Tsoukas MM (2016). Phototherapy in cosmetic dermatology. Clinics in Dermatol 34, 623–7
  5. Chol CW, Chol JW, Park KC, Youn SW (2011). Facial sebum affects the development of acne, especially the distribution of inflammatory acne. JEADV, 1-6
  6. Dai T, Gupta A, Murray CK, Vrahas MS, Tegos GP, Hamblin MR (2012). Blue light for infectious disea-ses: Propionibacterium acnes, Helicobacter pylori, and beyond?. Drug Resistance Updates 15, 223–36
  7. Fox L, Csongradi C, Aucamp, Plessis, Gerber M (2016). Treatment Modalities for Acne. Molecules 21, 1063-83
  8. Humphrey S (2012). Antibiotic resistance in acne treat-ment. Skin therapy Letter 17, 1-3
  9. Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezu-ka T (2002). Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation. J Dermatol Sci 30, 129-35
  10. Rimadhani M, Rahmadewi (2015). Antibiotik oral pada pasien Akne vulgaris: penelitian retrospektif. Berkala Ilmu Kesehatan Kulit dan Kelamin 27, 84-9
  11. Shnitkind E, Yaping E, Geen S, Shalita AR, Lee WL (2006). Anti-inflammatory properties of narrow-band blue light, J Drugs Dermatol 5, 605-10
  12. Webster GF (2010). Light and laser therapy for acne: sham or science? facts and controversies. Clinics in Dermatol 28, 31–3
  13. Youn SW (2009). The role of facial sebum secretion in acne pathogenesis:facts and controversies. J clin der-matol 28, 8-11
  14. Zaenglein AL, Graber EM, Thiboutot DM (2012) Acne vulgaris and acneiform eruptions. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's Dermatology in general medi-cine. 8th ed, New York, McGraw-Hill Inc, p 897-917

Most read articles by the same author(s)